CIK 0001857044 · Non-accelerated filer<br>Smaller reporting company
Indaptus Therapeutics, Inc.
Sign in to watch- Ticker
- INDP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863158720
- Phone
- (646) 427-2727
- Business address
- 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK, NY, 10019
- Former names
- Intec Parent Inc.
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Other events
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Executive or director change · Bylaws or fiscal year change · Other events
- 8-A12B Other Registration of Securities
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 17 of 18 · 343 filings